IPP Bureau
Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
By IPP Bureau - August 24, 2023
The company has entered into a three-year Deferred Prosecution Agreement
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
By IPP Bureau - August 24, 2023
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
By IPP Bureau - August 24, 2023
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
By IPP Bureau - August 24, 2023
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
By IPP Bureau - August 24, 2023
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
By IPP Bureau - August 23, 2023
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
By IPP Bureau - August 23, 2023
Eris Lifesciences enters into term loan agreement with Citi Bank
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
By IPP Bureau - August 23, 2023
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
LEO Pharma to acquire Timber Pharmaceuticals
By IPP Bureau - August 22, 2023
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors
By IPP Bureau - August 22, 2023
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
By IPP Bureau - August 22, 2023
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
By IPP Bureau - August 22, 2023
Oteseconazole Capsules were found to be safe and more effective than fluconazole
EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
By IPP Bureau - August 21, 2023
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Venus Remedies launches its flagship R&D drug Elores in Oman
By IPP Bureau - August 21, 2023
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
By IPP Bureau - August 21, 2023
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle














